Pilar Giraldo – Medical field – Lifetime achievement Award

Posted on by Leave a Comment on Pilar Giraldo – Medical field – Lifetime achievement Award

Pilar Giraldo – Medical field – Lifetime achievement Award

Dr. Pilar Giraldo distinguished academic and researcher in the field Identification of patient-reported outcome measures and patient-reported experience measures in Gaucher disease in Spain. Dr. Pilar Giraldo Castellano appears highly suitable for the Research for Lifetime Achievement Award based on her extensive contributions and accomplishments in the field of hematology, particularly focusing on rare diseases.

🌐 Professional Profile

Educations📚📚📚

  • PhD in Medicine and accredited as a Full Professor by ANECA.
  • Master’s in Research Methodology and Molecular Oncology.
  • Coordinator of Doctorate studies at University San Jorge.

  • Research and Publications:

    • Head of research group Unit 752 of the Center for Biomedical Research Network on Rare Diseases (CIBERER).
    • Published over 140 articles in peer-reviewed journals, more than 20 book chapters, and 5 monographs.
    • Holds 5 patents related to her field.

  • Leadership in Research Projects:

    • Principal Investigator in numerous significant projects, such as the National Plan project TED2021-131518B-C32.
    • Directed more than 20 doctoral theses.
    • Led various research initiatives focusing on lysosomal diseases and other hematological conditions.

  • International Recognition and Collaboration:

    • Organized national and international congresses, including the 12th EWGGD Congress in 2016.
    • Part of the Expert Committee of the IWGGD and the Task Force on GD of the EHA.
    • Collaborates extensively with international bodies and foundations.

  • Awards and Recognition:

    • Received multiple awards for her contributions and those of her research group members at national and international congresses.
    • Recognized for her innovative work in utilizing artificial intelligence and machine learning in medical research.

  • Teaching and Mentorship:

    • Directed numerous continuing education courses for physicians.

Created educational resources and has been involved in life-long learning activities.

📝🔬Publications📝🔬

  • Elstein D, Belmatoug N, Bembi B, Deegan P, Fernandez-Sasso D, Giraldo P,
    Göker-Alpan Ö, Hughes D, Lau H, Lukina E, Revel-Vilk S, Schwartz IVD, Istaiti M, Botha J,
    Gadir N, Schenk J, Zimran A; GOS Study Group. 2024. Twelve Years of the Gaucher
    Outcomes Survey (GOS): Insights, Achievements, and Lessons Learned from a Global
    Patient Registry.J Clin Med.13-12.
  • Wallace EL, Goker-Alpan O, Wilcox WR, Holida M, Bernat J, Longo N, Linhart
    A, Hughes DA, Hopkin RJ, Tøndel C, Langeveld M, Giraldo P, Pisani A, Germain DP, Mehta
    A, Deegan PB, Molnar MJ, Ortiz D, Jovanovic A, Muriello M, Barshop BA, Kimonis V,
    Vujkovac B, Nowak A, Geberhiwot T, Kantola I, Knoll J, Waldek S, Nedd K, Karaa A, BrillAlmon E, Alon S, Chertkoff R, Rocco R, Sakov A, Warnock DG.;. 2024. Head-to-head trial
    of pegunigalsidase alfa versus agalsidase beta in patients with Fabry disease and
    deteriorating renal function: results from the 2-year randomised phase III BALANCE
    study. J Med Genet.21-61, pp.520-530.
  • Serrano-Gonzalo I, de Frutos LL, Lahoz-Gil C, Delgado-Mateos F, FernándezGalán MÁ, Morales-Conejo M, Calle-Gordo MV, Ibarretxe-Gerediaga D, MadinaveitiaOchoa A, Albarracin-Arraigosa A, Balanzat-Muñoz J, Correcher-Medina P, García-Frade LJ,
    Hernández-Rivas JM, Labbadia F, López-Dupla JM, Lozano-Almela ML, Mora-Casterá E,
    Noya-Pereira MS, Ruíz-Guinaldo MÁ, Del Mar Tormo-Díaz M, Vitoria-Miñana I, ArévaloVargas I, Andrade-Campos M, Giraldo P. Real life data: follow-up assessment on Spanish
    3
    Gaucher disease patients treated with eliglustat. TRAZELGA project.. 2023. Real life data:
    follow-up assessment on Spanish Gaucher disease patients treated with eliglustat.
    TRAZELGA project. Orphanet J Rare Dis.18-1.
  • Stanescu S, Correcher Medina P, Del Castillo FJ, Alonso Luengo O, Arto
    Millan LM, Belanger Quintana A, Camprodon Gomez M, Diez Langhetée L, Garcia Campos
    O, Matas Garcia A, Perez-Moreno J, Rubio Gribble B, Visa-Reñé N, Giraldo-Castellano P,
    O’Callaghan Gordo M. 2023. Clinical Outcomes of Patients with Chronic Neuropathic
    Form of Gaucher Disease in the Spanish Real-World Setting: A Retrospective
    Study.Biomedicines.11-10.
  • Linhart A, Dostálová G, Nicholls K, West ML, Tøndel C, Jovanovic A, Giraldo P,
    Vujkovac B, Geberhiwot T, Brill-Almon E, Alon S, Chertkoff R, Rocco R, Hughes. 2023.
    Safety and efficacy of pegunigalsidase alfa in patients with Fabry disease who were
    previously treated with agalsidase alfa: results from BRIDGE, a phase 3 open-label study.
    Orphanet J Rare Dis. 18-1, pp.332.
  • Louw VJ, Fraser I, Giraldo P 2023. Management goals of type 1 Gaucher
    disease in South Africa: An expert Delphi consensus document on good clinical
    practice.PLoS One. 18-8.
  • Esther Valero Tena; Mercedes Roca Espiau; Jose Verdu Diaz; Jordi Diaz
    Manera; Marcio Andrade Campos; Pilar Giraldo Castellano. 2023. Advantages of digital
    technology in the assessment of bone marrow involvement in Gaucher’s disease. Front Med
    (Lausanne).

Mazen Juratli- Medicine- Outstanding Scientist Award

Posted on by Leave a Comment on Mazen Juratli- Medicine- Outstanding Scientist Award

Mazen Juratli- Medicine- Outstanding Scientist Award

Prof. Mazen Juratli distinguished academic and researcher in the field Medicine. He is a dedicated and accomplished Assistant Professor and Senior Consultant Surgeon with a strong background in General, Visceral, and Transplant Surgery, specializing in upper GI tumors, reflux surgery, and peritoneal carcinomatosis. His experience encompasses both the clinical and research facets of surgical oncology, demonstrating a steadfast dedication to advancing medical science and enhancing patient care. He is actively pursuing opportunities to make substantial contributions to the field of surgery and academic medicine, particularly in the realm of Upper GI and peritoneal carcinomatosis surgery, along with related areas.

🌐 Professional Profile

Educations📚📚📚

He earned his Ph.D. in Interdisciplinary Biomedical Science (IBS) from the Arkansas Nanomedicine Center at the University of Arkansas for Medical Sciences (UAMS) in Little Rock, AR, USA, completing his studies between January 2012 and May 2014. Prior to that, he attended medical school at Philipps University in Marburg, Germany, from October 2003 to November 2009.

 Experience:

He is currently an Assistant Professor and Senior Consultant Surgeon at the University Hospital of Muenster in Muenster, Germany, within the Department of Generalhttps://networkscience-conferences.researchw.com/?p=33910&preview=true, Visceral, and Transplant Surgery. He specializes as an Upper Gastrointestinal (GI) Surgeon, adept in robotic, minimally invasive, and open surgeries. Additionally, he heads the Stomach Cancer and Peritoneal Carcinomatosis Surgical Center, serves as Deputy Head of the Esophagus Cancer Center, and leads the Surgical Biobank. He is also the Principal Investigator (PI) for the Liquid Biopsy Research Group. His licensure and certifications include being a Senior Explant Surgeon for Donor Surgery: Liver and Kidney (since October 2023) and a Certified Center Surgeon for the Upper GI Tract (since January 2023). He is a member of the Board of Directors of the Interdisciplinary Working Group for Clinical Hemotherapy (IAKH e.V.) and holds an additional qualification in Specialized Visceral Surgery (Zusatzbezeichnung Spezielle Viszeralchirurgie) from the Ärztekammer Westfalen-Lippe, Germany, since September 2022. He became a Fellow of the European Board of Surgery (F.E.B.S.) in Surgical Oncology in September 2022 and has been an Assistant Professor (Privatdozent Dr. med. habil.) since January 2021. He has served as a Senior Consultant Surgeon (Oberarzt) in the Department of General, Visceral, and Transplant Surgery at the University Hospital of Muenster since September 2020. He obtained his German Board Certification in Visceral Surgery – Consultant Surgeon (Facharzt) from the Ärztekammer Hessen, Germany, in June 2019. He earned his Ph.D. from the University of Arkansas for Medical Sciences (UAMS) in Little Rock, AR, USA, in December 2014 and his Doctor of Medicine (Dr. med.) from Philipps University in Marburg, Germany, in December 2009, where he also obtained his German Federal License (Approbation) in November 2009.

Awards, Grants and Honors

He has received numerous awards, grants, and honors throughout his career. In 2024, he secured industrial grant funding from Johnson & Johnson for a project on surgical smoke exposure investigation in surgical safety, amounting to €169,681, and also received the German Society for General and Visceral Surgery (DGAV) Travel Award, valued at €5000. He earned abstract prizes for his pilot studies on diagnostic and prognostic tumor markers in adenocarcinomas of the gastroesophageal junction and extracellular vesicles as potential biomarkers for hepatocellular carcinoma, presented at Visceral Medicine 2023 in Hamburg and NRW-Visceral Medicine 2023 in Essen, each prize valued at €500. In 2022, he won another abstract prize for his work on the long-term effects of liver resection on circulating stem cells in hepatocellular carcinoma, presented at Visceral Medicine in Hamburg. He was recognized as a Medical Scientist by the Else Kröner-Forschungskolleg (EKFK) in 2018 and received a grant of €15,000 from the B. Braun-Stiftung the same year. In 2017, he was awarded €66,000 for young talent promotion by Frankfurt Research Promotion at Goethe University, Frankfurt am Main, Germany. His achievements also include the Frankfurt Research Prize of the Rudolf Geißendörfer Foundation in 2015, valued at €5,000, and a poster prize at the 19 Chirurgische Forschungstage in Würzburg, Germany, in 2015, valued at €500. He received the second prize for the Cancers Best Paper Award in 2015 and the German Academic International Network (GAIN) Travel Award to attend the 18th European Career Fair (ECF) in Boston, MA, USA, in 2014, valued at €2,000. He was honored with the People’s Choice award for Science as Art at the Nanotechnology for Health Care Conference in Petit Jean, AR, USA, in 2014. Additionally, he was granted $78,000 by the Arkansas Breast Cancer Research Program (ABCRP) in 2013 and received €50,000 from the DFG – German Research Foundation in 2012.

 

📝🔬Publications📝🔬

  • Jens Hoelzen, Lukas Fortmann, Dhruvajyoti Roy, Carsten Szardenings, Martina Holstein, Ann-Kathrin Eichelmann,Emile Rijcken,Brooke E. Frankauer, Peter Barth, Eva Wardelmann, Andreas Pascher, and Mazen A. Juratli. Robotic-Assisted Esophagectomy with Total Mesoesophageal Excision EnhancesR0-Resection in Patients with Esophageal Cancer – a single-center experience. Surgery 05/2024. In Press
  • Lamberty SA, Hoelzen JP, Katou S, Becker F, Juratli MA, Andreou A, Morgül MH, Pascher A, Strücker B. Validation of the IWATE Criteria in Robotic-Assisted Liver Resections. J Clin Med. 2024 May 3;13(9):2697. doi: 10.3390/jcm13092697. PMID: 38731226; PMCID: PMC11084793.
  • Juratli, M.A., Pollmann, N.S., Oppermann, E. et al. Extracellular vesicles as potential biomarkers for diagnosis and recurrence detection of hepatocellular carcinoma. Sci Rep 14, 5322 (2024). https://doi.org/10.1038/s41598-024-55888-8.
  • Diedrich AM, Daneshgar A, Tang P, Klein O, Mohr A, Onwuegbuchulam OA, von Rueden S, Menck K, Bleckmann A, Juratli MA, Becker F, Sauer IM, Hillebrandt KH, Pascher A, Struecker B. Proteomic analysis of decellularized mice liver and kidney extracellular matrices. J Biol Eng. 2024 Feb 22;18(1):17. doi: 10.1186/s13036-024-00413-8. PMID: 38389090; PMCID: PMC10885605
  • de Jongh C, Cianchi F, Kinoshita T, Kingma F, Piccoli M, Dubecz A, Kouwenhoven E, van Det M, Mala T, Coratti A, Ubiali P, Turner P, Kish P, Borghi F, Immanuel A, Nilsson M, Rouvelas I, Hӧlzen JP, Rouanet P, Saint-Marc O, Dussart D, Patriti A, Bazzocchi F, van Etten B, Haveman JW, DePrizio M, Sabino F, Viola M, Berlth F, Grimminger PP, Roviello F, van Hillegersberg R, Ruurda J; UGIRA Collaborative Group. Surgical Techniques and Related Perioperative Outcomes After Robot-assisted Minimally Invasive Gastrectomy (RAMIG): Results From the Prospective Multicenter International Ugira Gastric Registry. Ann Surg. 2023 Nov 3. doi: 10.1097/SLA.0000000000006147. Epub ahead of print. PMID: 37922237.
  • Hoelzen JP, Frankauer BE, Szardenings C, Roy D, Pollmann L, Fortmann L, Merten J, Rijcken E, Juratli MA, Pascher A. Reducing the Risks of Esophagectomies: A Retrospective Comparison of Hybrid versus Full-Robotic-Assisted Minimally Invasive Esophagectomy (RAMIE) Approaches. J Clin Med. 2023 Sep 7;12(18):5823. doi: 10.3390/jcm12185823. PMID: 37762765; PMCID: PMC10531670.Two senior authors
  • Peters AK, Juratli MA, Roy D, Merten J, Fortmann L, Pascher A, Hoelzen JP. Factors Influencing Postoperative Complications Following Minimally Invasive Ivor Lewis Esophagectomy: A Retrospective Cohort Study. J Clin Med. 2023 Aug 31;12(17):5688. doi: 10.3390/jcm12175688. PMID: 37685756; PMCID: PMC10488704.Contributed equally to the study
  • Mohr A, Besser M, Broichhausen S, Winter M, Bungert AD, Strücker B, Juratli MA,Pascher A, Becker F. The Influence of Apremilast-Induced Macrophage Polarization on Intestinal Wound Healing. J Clin Med. 2023 May 9;12(10):3359. doi: 10.3390/jcm12103359. PMID: 37240465; PMCID: PMC10219563

Haifang Wang – Evidence-based medicine – Excellence in Academic Research Award

Posted on by Leave a Comment on Haifang Wang – Evidence-based medicine – Excellence in Academic Research Award

Haifang Wang – Evidence-based medicine – Best Researcher Award

Dr. Haifang Wang  distinguished academic and researcher in the field Evidence based Medicine.

🌐 Professional Profile

Educations📚📚📚

He completed his Bachelor of Nursing Science at Changzhi Medical College from September 2005 to June 2010, followed by his Master of Nursing Science at Shanxi Medical University from September 2010 to June 2013. During his studies, he undertook courses such as Medical Statistics, Emergency and Critical Care Medicine, Clinical Epidemiology, Introduction to Clinical Medicine, Clinical Psychology, Theories and Methods of Health Education, Comprehensive Nursing, and Modern Nursing Development.

 Experience:

Since July 2007, he has been actively involved in gaining practical experience and advancing his career in the field of nursing. His journey began with a rotation internship at No.1 Hospital of Shanxi Medical University, which provided foundational exposure to various clinical practices until May 2008. Subsequently, he pursued specialized training with an ICU internship at No.1 Hospital of Shanxi Medical University from July to October 2011, honing his skills in critical care environments. His career path then led him to engage in clinical research at No.2 Hospital of Shanxi Medical University from January 2012 to December 2012, broadening his expertise in research methodologies. Since July 2013, he has been dedicated to educating future nurses at Linfen Vocational and Technical College, imparting both practical knowledge and theoretical foundations in Nursing Science.

Projects hosted and participated

He has been actively involved in various research projects since 2012, including presiding over initiatives such as the Nursing Fund Project at the Second Hospital of Shanxi Medical University, which focused on preventing pulmonary infections in lupus erythematosus patients using different gargles. His research continued with projects like the feasibility study of ultrasonic nebulized potassium chloride inhalation for hypokalemia conducted by the Shanxi Provincial Department of Health in 2013. In subsequent years, he participated in projects addressing the quality of life and self-management of patients with myasthenia gravis, occupational exposure of medical staff to body fluid splashing, and the application of technology in nursing education. His leadership was evident in 2019 when he presided over a college-level project investigating the concept map teaching method’s impact on vocational nursing students’ autonomous learning abilities and participated in key projects focusing on internet-based nursing service quality evaluations and educational science planning in Shanxi Province.

Textbook compilation

He has contributed significantly to the development of nursing education through various textbook publications and educational materials. His work includes co-authoring “Basic Nursing Technique” published by People’s Medical Publishing House, a textbook aligned with China’s 13th Five-Year Plan. Additionally, he has collaborated on “Community Nursing Science,” a digital integration teaching material for higher vocational colleges published by Huazhong University of Science and Technology Press. His expertise also extends to “Surgical Nursing Science,” where he contributed to school-based teaching materials published by Jiangsu University Press, emphasizing practical skills and theoretical knowledge essential for nursing students’ training and professional development.

Academic conference

06.11-09.11.2020 China Nursing Research Summit Forum
(Xiamen)
16.11-18.11.2018 Tianjin – China Nursing Management
Conference
16.11-18.11.2018 The national training course for teachers to
improve the practical ability of nursing major in vocational
colleges

📝🔬Publications📝🔬

  • “Analysis on the status quo of knowledge, belief and practice of
    occupational exposure protection for body fluid splashing in ENT
    medical staff”, “Modern Nursing”, 2019
  • “Motivational Interview: The Effect of Health Education on the
    Self-care Ability of Patients with Gestational Diabetes”, “Public
    Medical Forum Magazine”, 2019
  • “Literature Review and Analysis of Factors Affecting Compliance
    of Self-Glucose Monitoring in Chinese Type 2 Diabetes”,
    “Proceeding of Clinical Medicine” ,2016
  • “Clinical study of different gargles in preventing oral and lung
    infections in patients with lupus erythematosus during active
    period”, “Journal of Nursing Science”, 2013
  • “Oral-related factors and nursing research progress in systemic
    lupus erythematosus complicated with lung infection”, “Journal
    of Nursing Science”, 2013
  • “The practice of strengthening basic nursing in the development
    of high-quality nursing service in ICU”, “China Medicine and
    Pharmacy”, 2012

Africa Holguin – human immunodeficiency virus (HIV)- Women Researcher Award

Posted on by Leave a Comment on Africa Holguin – human immunodeficiency virus (HIV)- Women Researcher Award

Africa Holguin – human immunodeficiency virus (HIV)- Women Researcher Award

Dr. Africa Holguin distinguished academic and researcher in the field Human immunodeficiency virus (HIV). She is the Head of the HIV-1 Molecular Epidemiology Laboratory, affiliated with the Microbiology Department at Hospital Ramón y Cajal in Madrid and the Ramón y Cajal Health Research Institute (IRYCIS). As the leader of numerous national and international research projects, she secures funding from both public and private sources, oversees budget administration, and provides the essential expertise and leadership skills to guide and train her team successfully. She has authored over 150 scientific papers in international journals, often serving as the first or last author. Her research group collaborates with national partners and international public health agencies, focusing on well-established pediatric and adult populations across various countries. For more details on her publications, see her Google Scholar profile.

 

🌐 Professional Profile

Educations📚📚📚

She holds a Doctorate in Molecular Biology from Universidad Autónoma de Madrid, Spain, earned in 1996, and a Licentiate in Biological Sciences with a specialization in Biochemistry and Molecular Biology from the same university, completed in 1991. In 2011, she completed the “BIOCAMPUS 2011” Bioentrepreneurship training program, comprising 280 hours, organized by Fundación Genoma España. Additionally, she has undertaken more than 400 hours of training in leadership skills, human resources management, teamwork, coaching, leadership, negotiation, and strategy through various public courses organized by the Instituto de Administración Pública de Madrid (MAP) and the Dirección General de Función Pública de la Comunidad de Madrid.

Research Experiences

She is currently an Investigadora Titular del Sistema Nacional de Salud and the head of the HIV Molecular Epidemiology Laboratory at IRYCIS, Hospital Ramón y Cajal, in Madrid, a position she has held since 2022. Her career includes various roles, starting as a Becaria de Colaboración del MEC at the Centro de Biología Molecular “Severo Ochoa,” CSIC, in Spain from 1989 to 1990. She then served as a predoctoral fellow at the same institution from 1990 to 1996 and a visiting predoctoral researcher at the Dana Farber Cancer Institute, Harvard Medical School, in 1995. From 1996 to 2000, she was a postdoctoral fellow funded by the Fondo de Investigaciones Sanitarias (FIS) at Hospital Carlos III in Madrid. In 1997, she also worked as a visiting postdoctoral researcher at the Georg-Speyer-Haus Institute in Frankfurt, Germany. From 2000 to 2008, she was an investigator at the Sistema Nacional de Salud, Hospital Carlos III. Since 2006, she has been a stabilized investigator at the Fundación para la Investigación Sanitaria del Hospital Ramón y Cajal in Madrid.

Activities of technology / knowledge transfer and results exploitation

  • Actualmente la Unidad de Innovación del Instituto para la Investigación Sanitaria (IRYCIS)
    del Hospital Ramón y Cajal de Madrid está valorando la mejor vía de protección de unos
    aptámeros que reconocen específicamente regiones altamente conservadas de varias
    proteínas del VIH para una futura aplicación diagnóstica.
  • La Dra. Holguín es autora al 40% del programa BioInformático EpiMolBIo (Registro
    2305114294344 en SAFE CREATIVE S.L, 11-5-2023) para analizar secuencias genéticas
    de patógenos y de genes/proteínas de interés biomédico. Con él se analizó la conservación
    de la región de las 5 proteínas del virus usadas para seleccionar los aptámeros anti VIH
    de este proyecto (PMID:35495642, 35694284, 35910645, 33586996), y para estudiar la
    evolución del SARS-CoV-2 en España (PMID:35742840) y mundo (PMID:33557213)
📝🔬Publications📝🔬

1. Scientific paper. Valadés-Alcaraz, A.; Reinosa, R.; González-Hevilla, M.; Medina-Sánchez,
C.; Martín, M. A.; (6/6) Holguín, A. (AC). 2024. Development and characterization of
High-Affinity Aptamers for HIV Protease Detection. (Submitted).Nucleic Acids Research
(Open Acess). (JIF: 14.9, Decil 1 – 10/285, JCR 2022).

2. Scientific paper. Reinosa, R.; Troyano-Hernáez, P.; Valadés-Alcaraz, A.; (4/4) Holguín, A.
(AC). 2024. EpiMolBio: A Novel User-Friendly Bioinformatic Program for Genetic Variability
Analysis. (Submitted).Bioinformatics (Open Access). (JIF: 5.8, Q1 – 24/158 in Bioechnology
& applied Microbiology, JCR 2022).

3. Scientific paper. Rodríguez-Galet, A.; Ventosa-Cubillo, J.; Bendomo, V.; et al; (9/9)
Holguín, A. (AC). 2024. HIV Diagnosis in Equatorial Guinea. Keys to reduce the diagnostic
and therapeutic delay. (Submitted). Journal of Infection and Public Health (Open Acess).
(JIF: 6.7, Q1 – 18/96 in Infectious Diseases, JCR 2022).

4. Scientific paper. Martínez De Aguirre, P.; Carlos, S.; Pina-Sánchez, M.; et al; Reina,
G.; (8/9) Holguín, A.2024. High pre-Delta and early-Omicron SARS-CoV-2 seroprevalence
detected in dried blood samples from Kinshasa (D.R.Congo) (In press).Journal of Medical
Virology (Open Access). (JIF: 12.7, Decil 1 – 2/36, JCR 2022).

5. Scientific paper. Rodríguez-Galet, A.; Ventosa-Cubillo, J.; Eyene, M.; et al; (9/9) Holguín,
A. (AC). 2024. Immunity to six vaccine pathogens in HIV+ and HIV- children in Bata city,
Equatorial Guinea. (In press). Vaccines (Open Acess). (JIF: 7.8, Q1- 24/136 in Medicine,
Research & Experimental, JCR 2022).

6. Scientific paper. Epalza, C.; Valadés-Alcaraz, A.; González-Alba, J.M.; et al; (14/14)
Holguín, A. (AC). 2024. Transmitted Drug Resistance and HIV Diversity Among
Adolescents Newly Diagnosed With HIV in Spain.The Pediatric Infectious Disease Journal
(Open Acess). (JIF: 3.6, Q1 – 23/130 in Pediatrics, JCR 2022).43, pp.40-48. PMID:
37922511. https://doi.org/10.1097/INF.0000000000004138

7. Scientific paper. Mbuagbaw L; Garcia C; Brenner B; et al; Jordan, M.R.; (7/15)
Holguin, A.2023. Checklist for studies of HIV drug resistance prevalence or
incidence: rationale and recommended use.The Lancet HIV (Open Access). (JIF:
16.1, Decil 1 – 6/96 in Infectious Diseases, JCR 2022). 10, pp.e684-e689. PMID:
37716367. https://doi.org/10.1016/S2352-3018(23)00173-X

8. Scientific paper. Ventosa-Cubillo, J.; Pinzón, R.; González-Alba, J.M.; Estripeaut, D.;
Navarro, M.L.; (6/6) Holguín, A. (AC). 2023. Drug resistance in children and adolescents
with HIV in Panama.The Journal of Antimicrobial Chemotherapy (Open Access). (JIF:
5.2, Q1- 55/278 in Pharmacology & Pharmacy

Canan Uluoglu – Pharmacology – Best Researcher Award

Posted on by Leave a Comment on Canan Uluoglu – Pharmacology – Best Researcher Award

Canan Uluoglu – Pharmacology – Best Researcher Award

Dr. Canan Uluoglu distinguished academic and researcher in the field Pharmacology. She was awarded a postdoctoral scholarship at Ferrara University, where she worked in the Department of Clinical and Experimental Medicine’s Molecular and Cellular Pharmacology Unit from 2000 to 2001.

Her committee memberships include serving as a member of the Turkish Health Ministry’s Drug Regulatory Commission from 2015 to 2017, being a part of the Gazi University Clinical Research Ethics Committee from 2003 to 2018, and participating in the Turkish Scientific and Technological Research Council (TUBITAK) from 2010 to 2014.

Her research interests encompass Basic and Clinical Pharmacology, Chronopharmacology, and Neuropharmacology.

 

🌐 Professional Profile

Educations📚📚📚

She completed her medical education at Gazi University School of Medicine in Ankara, Turkey, graduating in 1989. In 1998, she became a Research Assistant and earned her PhD from the Department of Pharmacology at the same institution. Her academic career progressed as she was appointed as an Associate Professor in the Department of Pharmacology in 2003. By 2009, she had achieved the rank of Professor in the same department, continuing her contributions to the field of pharmacology at Gazi University School of Medicine.

📝🔬Publications📝🔬
  • ZS Ercan, RK Türker, C Uluoğlu, Ö Yazar, H Zengil. “The effects of endothelin peptides in the rabbit isolated perfused kidney.” General Pharmacology. 25(7):1471-1476 (1994). ISSN: 0306-3623
  • U Hodoğlugil, C Uluoğlu, HZ Güney, CZ Görgün, ZS Ercan, N Abacıoğlu, H Zengil. “Twenty-four-hour variations in the effect of nitrodilators in rat aorta: lack of influence of the endothelium”. Journal of Pharmacy and Pharmacology. 49(11):1102-1108 (1997). ISSN:2042-7158
  • HZ Güney, U Hodoğlugil, C Uluoğlu, CZ Görgün, ZS Ercan, N Abacıoğlu, H Zengil. In vitro susceptibility rhythms. II. Biological-time-dependent differences in effect of b1 -and b2 – adrenergic agonists of rat aorta and influence of endothelium. Chronobiology International. 15(2): 159-172 (1998). Print ISSN: 0742-0528 Online ISSN: 1525-6073
  • C Uluoğlu, HZ Güney, M Kılınç, Ş Bozkurt, ZS Ercan. “The effects of captopril and naloxone on restraint-cold-stress- and ethanol-induced gastric lesions in rats.” General Pharmacology. 30(5):701-704 (1998). ISSN: 0306-3623
  • C Uluoğlu, U Hodoğlugil, HZ Güney, CZ Görgün, N Abacıoğlu, H Zengil. “Daily variations in the responses to papaverine but not theophylline in rat aorta.” Biological Rhythm Research. 29(4): 343-352 (1998). ISSN: 0929-1016 Online ISSN: 1744-4179
  • C Uluoğlu, A Oğuz, Ö Timlioğlu, G Biberoğlu, A Hasanoğlu. “Intermediate dose of methotrexate toxicity in non-Hodgkin lymphoma.” General Pharmacology. 32(2): 215-218 (1999). ISSN: 0306-3623
  • U Hodoğlugil, ZA Keskil, CZ Görgün, C Uluoğlu, N Abacıoğlu, H Zengil. “Effect of time on endothelium-dependent relaxations in mice and rat thoracic aortas.” Biological Rhythm Research. 30(4): 434-444 (1999). Print ISSN: 0929-1016 Online ISSN: 1744-4179
  • O Uludağ, B Tunçtan, HZ Güney, C Uluoğlu, S Altuğ, H Zengil, N Abacıoğlu. “Temporal variation in serum nitrite levels in rats and mice.” Chronobiology International.  16(4): 527-532 (1999). ISSN: 1525-6073
  • HZ Güney, C Uluoğlu, U Hodoğlugil, CZ Görgün, T Yamanoğlu, N Abacıoğlu, H Zengil. “Biological-time-dependent differences in effect of verapamil in rat aorta and influence of endothelium.” Chronobiology International.  16(6): 779-787 (1999). ISSN: 1525-6073
  • C Uluoğlu, Timlioğlu Ö. “Endothelium-dependent vasodilation in the isolated rabbit kidney following in vivo and in vitro ischaemia-reperfusion: effects of antagonizing platelet activating factor (PAF). “Naunyn-Schmiedeberg’s Archives of Pharmacology. 360(3): 324-330 (1999).

Miguel Angel Rodríguez Cabello -Medicine and Health Sciences – Best Researcher Award

Posted on by Leave a Comment on Miguel Angel Rodríguez Cabello -Medicine and Health Sciences – Best Researcher Award

Miguel Angel Rodríguez Cabello -Medicine and Health Sciences – Best Researcher Award

Dr. Miguel Angel Rodríguez Cabello distinguished academic and researcher in the field Medicine and Health Sciences. He completed several postgraduate programmes at CEU and Cardenal Herrera University from October 2018 to July 2019, including expertise in Medical Direction and Health Services Management, Medical Direction and Management of Clinical Units, Quality Medical Management, and Leadership and Directing Skills in Health. Additionally, he earned a Certificate of Da Vinci System Training as a Console Surgeon on 16th October 2017, at EU Direct: IRCAD in Strasbourg, France. Currently, he is pursuing a Master’s Degree in Clinical, Medical, and Assistance Management at CEU and Cardenal Herrera University. He participated in the Salzburg ESU Weill Cornell Seminar in Masterclass in Urology in Salzburg, Austria, from 9th to 15th July 2017, earning 37 DFP credits from the Austrian Chamber of Physicians. He is a member of EU-ACME, the European Board of Urology (EBU), and the European Association of Urology (EAU).

He completed a hands-on training course on Laparoscopy and Endourology, accredited by the European Accreditation Council for Continuing Medical Education, earning 24 European CME credits from 31st January to 3rd February 2017 in Cáceres, Spain. He also participated in the European Training in Basic Laparoscopic Urological Skills (E-BLUS) on 13th March 2016 at the 31st Annual Congress of the European Association of Urology in Munich, Germany, under Dr. J. Palou. He became a Fellow of the European Board of Urology (F.E.B.U.) after passing the EBU Written Examination on 14th November 2014 with a qualification of 8, and the EBU Oral Examination on 6th June 2015 in Brussels, Belgium, with a successful qualification of 7/9.

He completed a postgraduate programme on expertise in Urological Ultrasound at the University of Zaragoza during the VI Course 2015–2016. He holds a Diploma in Design and Statistics and a Master’s Degree in Research Methodology from Universidad Autónoma de Barcelona (Spain). Additionally, he completed a postgraduate programme on expertise in Statistics Applied to Health Sciences at UNED during the 2012-2013 academic year, earning an outstanding qualification and 20 ECTS credits (500 hours).

🌐 Professional Profile

Educations📚📚📚

He holds a PhD in Medicine and Surgery from Universidad Autónoma de Madrid, awarded on 9th June 2023, with his thesis receiving an Outstanding qualification with Cum Laude mention by unanimity. He also earned two Postgraduate Diplomas in 2023 from Universidad Autónoma de Barcelona: one in Systematic Review of Studies: Meta-Analysis and Evaluation Tests, and another in Systematic Review of Studies: Synthesis of Information. In March 2023, he completed the Aquablation Therapy Training Programme, receiving a Certificate of Completion from Procept BioRobotics. He holds a Master’s Degree in Research Methodology: Design and Statistics in Health Sciences from Universidad Autónoma de Barcelona, which he completed between 2017 and 2021. Additionally, he completed the Rezūm Procedure Healthcare Practitioner Training in August 2020, acknowledged by Boston Scientific. His academic achievements also include a Diploma in Design and Statistics and a Master in Research Methodology from Universidad Autónoma de Barcelona, obtained between 2016 and 2020. Furthermore, he holds a Master’s Degree in Clinical, Medical, and Care Management.

 

Work Experience

He has been working as a Physician Specialist in Urology at University Hospital La Moraleja in Madrid since May 2015 and as a Physician Specialist in Urology and Infertility at OVOCLINIC in Madrid since September 2021. Previously, he was a resident at the Urology Department of University Hospital Ramón y Cajal in Madrid, Spain, from May 2010 to May 2015, and worked as a General Physician at Company Medycsa, Calle Valentín Beato 5, Madrid, between 2009 and 2010. He completed a Fellowship in Laparoscopic and Robotic Urological Surgery at Saint Augustin Clinic, Bordeaux (France) from September to November 2014 and participated in the Salzburg ESU Weill Cornell Seminar in Masterclass in Urology, organised by the European Association of Urology, European School of Urology (ESU), and Weill Cornell Medicine, earning 37 DFP credits from the Austrian Chamber of Physicians in Salzburg, Austria, from 9th to 15th July 2017. From 2010 to 2014, he was a Professor of Urology at CTO Medicina, delivering 180 hours of lectures under the direction of Dr. Roberto Garcia Leal. He supervised residents during their incorporation into the Department of Urology and provided education and oversight to students of the Medicine Degree at Universidad Francisco de Vitoria as well as to residents of Gynecology.

From 2020 to 9th June 2023, he was a Ph.D. student in Medicine and Surgery at Universidad Autónoma de Madrid, where he studied the diagnostic validity of predictive models in prostate cancer using the Prostate Imaging and Data Reporting System version 2 (PIRADSv2) and PSA density. Since 2023, he has been the principal investigator of a randomised, double-blind, placebo-controlled study evaluating the effect of a probiotic on urinary tract microbiota in women with recurrent urinary tract infections (rUTI), study code IC-HULM-007-23, known as the PROBUTI study. Since 2021, he has been an independent technical evaluator of research projects, R+D+I, and technological innovation. He is currently the principal investigator in the Prostate Imaging using MRI +/- contrast Enhancement (PRIME) study at University College London (UCL), which assesses whether bi-parametric MRI is non-inferior to multi-parametric MRI in diagnosing clinically significant prostate cancer. Additionally, he actively collaborates as the principal investigator in the phase 3 clinical trial E.mbrace Amendment 2 VAC52416 (JNJ-78901563 [ExPEC9V]), a study aimed at assessing the efficacy, safety, and immunogenicity of vaccination with ExPEC9V in preventing invasive extraintestinal pathogenic Escherichia coli disease in adults aged 60 years and older with a history of urinary tract infection in the past two years.

His ongoing research projects include a comparative study between multiparametric magnetic resonance systems of 1.5 and 3 Teslas using the PIRADS version 2 classification in the diagnosis of prostate cancer (registered under number 40/2021); a cross-sectional study of PSA density assessment and multiparametric resonance as predictors of prostate cancer (registered under number 39/2021); and the evaluation of the Oncotype Dx genetic test in therapeutic decisions for low-risk prostate cancer, a multicenter study (registered under number 29/2021). From 2020 to the present, he has been conducting research on predictive models and validation of diagnostic tests in prostate cancer, focusing on multiparametric prostate MRI and fusion prostate biopsy as part of his PhD at Universidad Autónoma de Madrid. Between 2018 and 2019, he actively collaborated in the RITUMAN study, a multicenter and coordinated study on the management of patients with recurrent urinary tract infections. From 2016 to 2017, he contributed to the PREVENT-LIT study, which focused on the management of patients with urolithiasis. From 2011 to 2013, he participated in the EMPARO-CU study, a multicenter and coordinated study examining the care process and outcomes in a cohort of patients diagnosed with urological cancer (bladder and prostate).

 

📝🔬Publications📝🔬
  • Giganti F, Ng A, Asif A, Chan VW, Rossiter M, Nathan A, Khetrapal P, Dickinson L,
    Punwani S, Brew-Graves C, Freeman A, Emberton M, Moore CM, Allen C,
    Kasivisvanathan V; PRIME Quality Improvement Group. Global Variation in Magnetic
    Resonance Imaging Quality of the Prostate. Radiology. 2023 Oct;309(1):e231130. doi:
    10.1148/radiol.231130. PMID: 37815448. Contributor.
  • Miguel Angel Rodríguez Cabello, Santiago Méndez Rubio, Juan Luis Sanz Miguelañez,
    Alvaro Moraga Sanz, Carolina Aulló González, Arturo Platas Sancho. Prevalence and
    grade of malignancy differences with respect to the area of involvement in
    Curriculum Vitae
    Miguel Ángel Rodríguez Cabello
    5
    multiparametric resonance imaging of the prostate in the diagnosis of prostate
    cancer using the PI-RADS version 2 classification. World J Urol. 2023 May 30. DOI:
    10.1007/s00345-023-04466-0.
  • Cabello, R., Mendez Rubio, S., Sanz Miguelanez, J. L., Vazquez Alba, D., Moraga Sanz, A.,
    & Platas Sancho, A. (2023, February). The importance of the location of the PI-RADS
    lesion within the prostate as a predictive variable of malignant degree. In EUROPEAN
    UROLOGY (Vol. 83, pp. S432-S432). RADARWEG 29, 1043 NX AMSTERDAM,
    NETHERLANDS: ELSEVIER.
  • Rodríguez Cabello MA, Méndez Rubio S, Platas Sancho A, Carballido Rodríguez J.
    Diagnostic evaluation and incorporation of PSA density and the prostate imaging
    and data reporting system (PIRADS) version 2 classification in risk-nomograms for
    prostate cancer. World J Urol. 2022 Oct;40(10):2439-2450. doi: 10.1007/s00345-022-
    04118-9. Epub 2022 Aug 8. PMID: 35941245.
  • Rodríguez Cabello, M.A., Méndez Rubio, S., Moraga Sanz, A., Sanz Miguelañez, J.L.,
    Vázquez Alba, D., Aulló González, C., Platas Sancho, A. Comparative study between
    1.5 and 3 Tesla multiparametric magnetic resonance imaging systems using the
    PIRADS version 2 classification in the diagnosis of prostate cancer. Arch-Esp-Urol
    2022;75(4):330–8.
  • Garrido-Abad P, Rodriguez-Cabello MÁ, Platas-Sancho A. Steinstrasse following
    extracorporeal shock wave lithotripsy. Arch Esp Urol. abril de 2021;74(3):363-4.
    PMID: 33818435.

Panagiotis Karanis – Biomedical Research – Best Researcher Award

Posted on by Leave a Comment on Panagiotis Karanis – Biomedical Research – Best Researcher Award

Panagiotis Karanis – Biomedical Research

Dr. Panagiotis karanis  distinguished academic and researcher in the field Biomedical research, infectious diseases, climate changes.  Professor Karanis is a resourceful and dedicated professor with an impressive academic background,
excellent publication record and significant teaching experiences in the fields of Emerging Infectious
Parasitic and Tropical Diseases and Human Anatomy. Possesses excellent interpersonal and liaison skills
with the ability to build and maintain positive working relationships. Possesses mature administrative and
managerial skills and solid experience in science policy and public health. Enjoys worldwide collaborating
in a productive and successful team and thrives in challenging environments. He was 1000 Talent Plan
Expert (2014-2017) in Qinghai, China.

🌐 Professional Profiles

Educations: 📚🎓

Professor Dr. Panagiotis Karanis has held various esteemed positions in the field of anatomy and biomedicine, showcasing an extensive and distinguished career spanning several decades. From 2019 to the present, he serves as a Professor of Anatomy and the Coordinator of the Unit of Anatomy & Morphology at the Medical School, University of Nicosia, Nicosia, Cyprus. His contributions extend globally, as he has been an international advisor, consultant, and visiting professor at numerous universities.

During the period from 2014 to 2018, Professor Karanis held the position of Professor and Director of the Centre of Biomedicine and Infectious Diseases at the State Key Laboratory for Plateau Ecology and Agriculture at Qinghai University in Xining, China. His expertise was recognized internationally, as he was selected as a Foreign Expert in the 1000 Talent Plan, Recruitment Program of Foreign Experts (RPFE) for non-ethnic Chinese experts in China.

Earlier in his career, from 2009 to the present, Professor Karanis made significant contributions as a Professor of Anatomy at the Medical School, University of Cologne, Germany. Prior to this, he served as an Associate Professor and later as a Full Professor at the National Research Centre for Protozoan Diseases (NRCPD) in Japan from 2006 to 2007.

The trajectory of Professor Karanis’s career is marked by academic achievements. In 1999, he received Venia legendi in Parasitology (PD Dr.) and completed his Habilitation in Clinical-Theoretical Medicine at the Medical Faculty, University of Bonn, Germany. His academic journey began with a PhD in Parasitology, focusing on ‘UV-Disinfection of Protozoan Parasites’ at the University of Bonn in 1992. Earlier, in 1987, he earned a Diploma in Biology from the University of Bochum, Germany.

Professor Karanis’s educational background is diverse, including studies in Biology at the Universities of Bielefeld, Düsseldorf, and Bochum from 1980 to 1986. He also pursued complementary studies of Medicine at the Universities of Bochum and Cologne, completing the pre-clinical medical curriculum. His commitment to academia and research has made him a respected figure in the international scientific community, contributing significantly to the fields of anatomy, biomedicine, and parasitology.

Research Interests: 🧬🔬

Biomedical research, infectious diseases, climate changes,Applications of Network Science and Graph Analytics in Social, Biological, and Technological Networks

Awards and Achievements: 🏆👏

  •  Prof. Karanis is included on the annual list of 100,000 top scientists worldwide and, correspondingly, in
    the top 2 per cent of scientists in their field, according to a team of researchers at Stanford University in
    the USA. The updated 2020 list is based on a range of citation metrics that provides standardized data
    across those fields and subfields, in arriving at the (2019) single year impact result of more than 8,000,000
    scientists worldwide.
  • Gained worldwide administrative and managerial skills and experiences in science policy and public
    health. Successfully established 5 Laboratories / Institutions in Bonn / Germany (Waterborne and Vectorborne
    Parasitic Diseases), Thessaloniki / Greece (Leishmania and Sandflies), Cologne / Germany (Medical and
    Molecular Parasitology), Obihiro / Japan (Unit for Diseases Control and Genetics), Xining / China (Centre
    of Biomedicine and Infectious Diseases; the laboratory was promoted from the Chinese Government toState Key Laboratory of the Qinghai Province in China, 2016). The laboratories in Germany, Japan and
    China achieved an international reputation
  • Developed worldwide effective cooperations between many countries, in particular betweenEuropean
    and Asian countries
  •  Consultant at Qatar National Research Foundation and Qatar University, Doha, Qatar
  • Academic program review for the Master of Science in Biomedical Science, College of Health
    Sciences at Qatar University, Doha, Qatar, September 2018
  • Consultant” at Walailak University, Nakhon Si Thammarat, Thailand
  • Nominated as “Advisory Board Member” of the “Centre of Excellence for Medical Research and
    Innovative Products (CEMRIP)” in Thailand.
  • Nominated “National Distinguished Expert” and “State Specially Recruited Expert” of China
  • Selected in 1000 Talent Plan, the Recruitment Program of Foreign Experts (RPFE) for non-ethnic Chinese
    experts, China, 2014, leading into ongoing innovative and promising collaborations with China
  • Invitation for Short Term – Fellowship – Program for Malaria Research in Japan by JSPS (Japanese
    Society of Promotion of Science), 12th January – 11th March 2014

Career Summary 

Dr. Panagiotis Karanis is a distinguished parasitologist with a wealth of expertise and a prolific career spanning several prestigious institutions across the globe. Serving as a Guest Professor at the University of Padova in Italy during 2019 and 2020, as well as a Consultant at the College of Public Health in Qatar in 2018, he contributed significantly to the field of parasitology. Dr. Karanis has been a Consultant at Walailak University in Thailand since 2017, where he has provided guidance and international supervision for PhD students.

His academic endeavors include roles as an Invited Professor at the University of Alexandroupolis and the University of Ioannina in Greece, where he delivered lectures on infectious diseases to both undergraduate and postgraduate students. Notably, from 2014 to 2018, Dr. Karanis held the position of Professor and Director of the Centre of Biomedicine and Infectious Diseases at Qinghai University in China.

As a Foreign Expert in the 1000 Talent Plan Recruitment Program, he played a pivotal role in elevating the laboratory to the State Key Laboratory for Plateau Ecology and Agriculture of the Qinghai Province. Dr. Karanis’s contributions extended to advising the Chinese government on research ideas, particularly in waterborne and vectorborne diseases, and his efforts in developing Cryptosporidium culture assays for drug testing garnered recognition and funding from prestigious institutions such as the Bill and Melinda Gates Foundation. His comprehensive involvement in academia, research, and international collaborations underscores his commitment to advancing the field of parasitology and infectious diseases.

 

📚Top Noted Publication